Equities

Pacific Biosciences of California Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Pacific Biosciences of California Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.46
  • Today's Change-0.01 / -0.68%
  • Shares traded3.70m
  • 1 Year change-13.10%
  • Beta2.1606
Data delayed at least 15 minutes, as of Jul 14 2025 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.

  • Revenue in USD (TTM)152.36m
  • Net income in USD-657.75m
  • Incorporated2000
  • Employees575.00
  • Location
    Pacific Biosciences of California Inc1305 O'brien DriveMENLO PARK 94025United StatesUSA
  • Phone+1 (650) 521-8000
  • Fax+1 (302) 636-5454
  • Websitehttps://www.pacb.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Simulations Plus Inc78.56m7.26m341.08m243.0047.511.8022.344.340.3570.3573.879.430.3974--4.18323,308.703.676.103.926.4555.2874.019.2418.97----0.0045.6417.5215.56-0.07033.0117.070.00
Outset Medical Inc115.27m-113.82m343.64m354.00--2.07--2.98-5.37-5.372.849.590.35611.323.14325,629.90-35.16-40.67-40.46-46.8035.9315.62-98.74-140.086.74-7.240.3565---12.8049.7925.94---22.65--
Treace Medical Concepts Inc210.82m-52.99m377.43m477.00--3.59--1.79-0.8506-0.85063.381.670.941.136.89441,968.60-23.63-24.03-28.77-29.1780.2580.99-25.13-24.973.36-49.020.3365--11.8939.65-12.55--57.11--
AngioDynamics, Inc.283.32m-41.39m378.46m748.00--2.05--1.34-1.02-1.026.964.540.92852.136.10378,770.10-13.57-16.38-18.54-18.7054.3652.95-14.61-30.491.40--0.0328---10.282.35-251.53--13.09--
Senseonics Holdings Inc23.68m-74.00m394.46m117.00--9.24--16.66-0.1146-0.11460.03610.05380.22163.525.72202,410.30-69.25-71.11-85.78-94.757.19-14.81-312.47-594.096.49-17.870.4983--0.36621.08-30.18--16.46--
Delcath Systems Inc53.85m-14.21m394.93m96.00--4.73--7.33-0.5058-0.50581.632.400.87261.516.95560,937.50-23.02-94.54-27.11-143.9784.9081.31-26.38-339.8514.61--0.00--1,701.7088.1044.66--87.69--
Orthofix Medical Inc804.53m-143.07m432.95m1.62k--0.9427--0.5381-3.70-3.7020.8411.720.93051.346.25497,852.10-16.55-10.81-19.95-13.3467.1570.31-17.78-11.571.50-1.930.2767--7.0811.6916.78--8.75--
Cytek Biosciences Inc197.05m-11.25m436.97m663.00--1.16--2.22-0.0864-0.08641.512.980.40431.773.74304,089.50-2.310.3407-2.640.381154.9458.12-5.710.86784.95--0.0128--3.8528.2050.44--30.83--
Pacific Biosciences of California Inc152.36m-657.75m441.12m575.00--4.81--2.90-2.29-2.290.54160.30540.12042.024.92264,968.70-51.98-16.31-55.02-17.7119.4934.48-431.72-156.405.87-50.680.8758---23.1911.12-1.02--16.89--
Surmodics Inc121.58m-19.86m441.42m389.00--4.00--3.63-1.40-1.408.557.710.70272.065.49312,532.10-11.48-3.99-12.70-4.6673.3780.25-16.34-6.263.99-1.890.2118---4.914.73-651.43---12.34--
Butterfly Network Inc85.62m-64.70m447.59m190.00--1.87--5.23-0.298-0.2980.39240.96950.28410.46855.07450,652.60-21.47---24.95--60.65---75.56-190.034.43--0.00--24.52--45.78------
Mesa Laboratories Inc240.98m-1.97m471.46m730.00--2.9520.901.96-0.364-0.36444.2829.300.54763.115.95330,106.80-0.4486-8.81-0.5876-9.7162.6161.73-0.8192-25.150.47161.570.5268--11.4715.4199.22--24.600.00
Myriad Genetics Inc831.30m-101.40m492.23m2.70k--0.6985--0.5921-1.12-1.129.147.650.78559.436.97307,888.90-9.58---11.15--70.01---12.20--1.71-52.350.0776--11.21--51.65------
Applied Energetics Inc2.50m-9.70m496.90m21.00--115.73--198.59-0.0452-0.04520.01170.01970.5558--12.29119,148.60-214.77-139.08-317.86-208.3649.2660.61-386.44-473.16----0.00---7.78---24.71--51.42--
Standard Biotools Inc169.69m-132.76m501.37m818.00--1.10--2.95-0.355-0.3550.45351.200.252.184.85207,441.30-19.56-29.45-22.51-35.6847.0450.11-78.24-79.685.37--0.0007--64.038.27-147.67--26.98--
LifeMD Inc234.01m-13.83m511.74m304.00------2.19-0.3335-0.33355.47-0.05353.4610.5330.14769,761.00-15.05-109.71-79.98-396.0387.9985.59-4.34-33.120.7718-3.191.02--39.2776.327.23------
Data as of Jul 14 2025. Currency figures normalised to Pacific Biosciences of California Inc's reporting currency: US Dollar USD

Institutional shareholders

54.23%Per cent of shares held by top holders
HolderShares% Held
ARK Investment Management LLCas of 31 Mar 202536.48m13.32%
Madrone Advisors LLCas of 31 Mar 202523.39m8.54%
Edmond de Rothschild Asset Management (France) SAas of 31 Mar 202521.86m7.98%
BlackRock Fund Advisorsas of 31 Mar 202520.44m7.46%
The Vanguard Group, Inc.as of 31 Mar 202515.87m5.80%
Nikko Asset Management Americas, Inc.as of 31 Mar 20259.57m3.49%
SSgA Funds Management, Inc.as of 31 Mar 20256.38m2.33%
Geode Capital Management LLCas of 31 Mar 20256.32m2.31%
T. Rowe Price Investment Management, Inc.as of 31 Mar 20254.89m1.79%
Jackson Square Partners LLCas of 31 Mar 20253.32m1.21%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.